Showing results (491-500 of 17,005) with videos related to
Sort By:
Pageof 1,701
Bioorganic & Medicinal Chemistry|March 3, 2009
Targeted delivery of compounds to Trypanosoma brucei using the melamine motifConstance Chollet, Alessandro Baliani, Pui Ee Wong, et al.Bioorganic & Medicinal Chemistry|March 3, 2009
Design and synthesis of 4-methoxyphenylacetic acid esters as 15-lipoxygenase inhibitors and SAR comparative studies of themHamid Sadeghian, Neda Attaran, Zeinab Jafari, et al.Bioorganic & Medicinal Chemistry|May 21, 2009
Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitorsJiajia Mou, Hao Fang, Fanbo Jing, et al.Bioorganic & Medicinal Chemistry|February 24, 2009
Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidinesIvana Stolić, Katarina Misković, Anahi Magdaleno, et al.Bioorganic & Medicinal Chemistry|February 24, 2009
Inspired by flowers: synthetic routes to scalemic deltamethrinic acidAlain Krief, Stephane Jeanmart, Adrian KremerBioorganic & Medicinal Chemistry|February 24, 2009
Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of actionChad A Van Huis, Agustin Casimiro-Garcia, Christopher F Bigge, et al.Bioorganic & Medicinal Chemistry|June 23, 2009
Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure-activity relationshipsClaudio Luis Donnici, Maria Helena Araújo, Henrique S Oliveira, et al.Bioorganic & Medicinal Chemistry|June 23, 2009
Computational selection of inhibitors of Abeta aggregation and neuronal toxicityDeliang Chen, Zane S Martin, Claudio Soto, et al.Bioorganic & Medicinal Chemistry|June 23, 2009
Bioactive conformation analysis of cyclic imides as protoporphyrinogen oxidase inhibitor by combining DFT calculations, QSAR and molecular dynamic simulationsLi Zhang, Ge-Fei Hao, Yin Tan, et al.Bioorganic & Medicinal Chemistry|June 23, 2009
Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancerAaron M LeBeau, Sangeeta R Banerjee, Martin G Pomper, et al.Pageof 1,701